BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 27402873)

  • 1. Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
    Pauling JD; Yu L; Frech TM; Herrick AL; Hummers LK; Shah AA; Denton CP; Saketkoo LA; Withey J; Khanna D; Domsic RT
    Rheumatology (Oxford); 2024 May; 63(5):1281-1290. PubMed ID: 37481713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis.
    Klotsche J; Torok KS; Kasapcopur O; Adrovic A; Terreri MT; Sakamoto AP; Katsicas M; Sztajnbok F; Marrani E; Sifuentes-Giraldo A; Stanevicha V; Anton J; Feldmann B; Kostik M; Nemcova D; Santos MJ; Appenzeller S; Avcin T; Battagliotti C; Berntson L; Bica B; Brunner J; Eleftheriou D; Harel L; Horneff G; Kallinich T; Minden K; Nielsen S; Patwardhan A; Helmus N; Foeldvari I
    J Scleroderma Relat Disord; 2023 Oct; 8(3):183-191. PubMed ID: 37744052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.
    Ross L; Hansen D; Proudman S; Khanna D; Herrick AL; Stevens W; ; ; Baron M; Nikpour M;
    Arthritis Rheumatol; 2024 Jun; ():. PubMed ID: 38937146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on disease activity of immunological disorders to correlate with thyroid function and other associated correlations.
    Pawar A; Joshi P; Singhai A
    J Family Med Prim Care; 2024 Mar; 13(3):896-902. PubMed ID: 38736834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets.
    De Lorenzis E; Kakkar V; Di Donato S; Wilson M; Barnes T; Denton C; Derrett-Smith E; Douglas K; Helliwell P; Herrick AL; Saleem B; Nisar M; Morley C; Green L; Alcacer-Pitarch B; Del Galdo F
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Systemic Sclerosis Patients, Peripheral Blood CD21
    Pellicano C; Colalillo A; Carnazzo V; Redi S; Basile V; Marino M; Basile U; Rosato E
    J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study.
    Ren Y; Tian J; Shi W; Feng J; Liu Y; Kang H; Chen B; He Y
    BMC Ophthalmol; 2023 May; 23(1):229. PubMed ID: 37217899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-soluble ST2 and systemic sclerosis arthropathy.
    Colalillo A; Pellicano C; Rosato E
    Clin Rheumatol; 2023 Mar; 42(3):871-877. PubMed ID: 36098853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.
    Tizaoui K; Yang JW; Lee KH; Kim JH; Kim M; Yoon S; Jung Y; Park JB; An K; Choi H; Song D; Jung H; Ahn S; Yuh T; Choi HM; Ahn JH; Kim Y; Jee S; Lee H; Jin S; Kang JG; Koo B; Lee JY; Min KM; Yoo W; Rhyu HJ; Yoon Y; Lee MH; Kim SE; Hwang J; Koyanagi A; Jacob L; Park S; Shin JI; Smith L
    Int J Biol Sci; 2022; 18(9):3731-3746. PubMed ID: 35813465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods of assessment of joint involvement in various systemic connective tissue diseases.
    Kardas T; Wielosz E; Majdan M
    Reumatologia; 2022; 60(1):53-62. PubMed ID: 35645418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory arthritis in systemic sclerosis: What to do?
    Blank RB; Nwawka OK; Yusov AA; Gordon JK
    J Scleroderma Relat Disord; 2019 Feb; 4(1):3-16. PubMed ID: 35382152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
    Saketkoo LA; Frech T; Varjú C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirják L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell AM; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101707. PubMed ID: 34538573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS Cohort.
    Buni M; Joseph J; Pedroza C; Theodore S; Nair D; McNearney TA; Draeger HT; Reveille JD; Assassi S; Mayes MD
    J Rheumatol; 2019 Dec; 46(12):1597-1604. PubMed ID: 30709959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of disease activity indices using the 28 joint counts in systemic sclerosis.
    Lóránd V; Bálint Z; Komjáti D; Németh B; Minier T; Kumánovics G; Farkas N; Czirják L; Varjú C;
    Rheumatology (Oxford); 2016 Oct; 55(10):1849-58. PubMed ID: 27402873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of composite disease activity indices for rheumatoid arthritis.
    Matsui T; Kuga Y; Nishino J; Kaneko A; Eto Y; Tohma S
    Mod Rheumatol; 2011 Apr; 21(2):134-43. PubMed ID: 20972600
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.